We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.2B
AUM Growth
-$255M
Cap. Flow
-$342M
Cap. Flow %
-28.37%
Top 10 Hldgs %
51.29%
Holding
4,943
New
709
Increased
1,153
Reduced
1,646
Closed
1,310

Sector Composition

Rank Sector Weight
1 Technology 2.73%
2 Financials 2.53%
3 Healthcare 2.3%
4 Consumer Discretionary 2.11%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMAB icon
1601
Grupo Aeroportuario Centro Norte
OMAB
$5.33B
$33K ﹤0.01%
549
+497
+956% +$27.1K
PHG icon
1602
Philips
PHG
$26.1B
$33K ﹤0.01%
845
+98
+13% +$3.54K
PLYM
1603
DELISTED
Plymouth Industrial REIT
PLYM
$33K ﹤0.01%
1,787
+1,687
+1,687% +$31.1K
RHP icon
1604
Ryman Hospitality Properties
RHP
$7.63B
$33K ﹤0.01%
385
+344
+839% +$29.6K
SAIA icon
1605
Saia
SAIA
$9.72B
$33K ﹤0.01%
+353
New +$33.4K
SHYF
1606
DELISTED
The Shyft Group
SHYF
$33K ﹤0.01%
1,823
+1,540
+544% +$25.7K
SONM icon
1607
DNA X Inc
SONM
$5.63M
$33K ﹤0.01%
5
+2
+67% +$9.87K
VMI icon
1608
Valmont Industries
VMI
$9.53B
$33K ﹤0.01%
220
+35
+19% +$4.95K
WNS
1609
DELISTED
WNS Holdings
WNS
$33K ﹤0.01%
501
+27
+6% +$1.68K
LBC
1610
DELISTED
Luther Burbank Corporation Common Stock
LBC
$33K ﹤0.01%
2,873
+1,954
+213% +$22.2K
NP
1611
DELISTED
Neenah, Inc. Common Stock
NP
$33K ﹤0.01%
470
-143
-23% -$9.72K
CMD
1612
DELISTED
Cantel Medical Corporation
CMD
$33K ﹤0.01%
469
-840
-64% -$60.9K
MDR
1613
DELISTED
McDermott International
MDR
$33K ﹤0.01%
49,232
+44,173
+873% +$56.5K
WLL
1614
DELISTED
Whiting Petroleum Corporation
WLL
$33K ﹤0.01%
+60
New +$29K
LJPC
1615
DELISTED
La Jolla Pharmaceutical Company
LJPC
$33K ﹤0.01%
8,399
+8,343
+14,898% +$49.3K
BOX icon
1616
Box
BOX
$4.6B
$32K ﹤0.01%
1,911
-2,579
-57% -$43.3K
CGEN icon
1617
Compugen
CGEN
$228M
$32K ﹤0.01%
+5,367
New +$27.6K
CMTL icon
1618
Comtech Telecommunications
CMTL
$51.8M
$32K ﹤0.01%
910
+619
+213% +$21.3K
CTMX icon
1619
CytomX Therapeutics
CTMX
$754M
$32K ﹤0.01%
3,856
+2,202
+133% +$14.9K
CULP icon
1620
Culp Inc
CULP
$44.1M
$32K ﹤0.01%
2,332
+1,761
+308% +$27K
HCA icon
1621
HCA Healthcare
HCA
$89.5B
$32K ﹤0.01%
217
-8,102
-97% -$1.09M
HTH icon
1622
Hilltop Holdings
HTH
$2.24B
$32K ﹤0.01%
1,302
+1,123
+627% +$27.4K
BRSL
1623
Brightstar Lottery PLC
BRSL
$2.03B
$32K ﹤0.01%
2,187
-8,771
-80% -$125K
KEYS icon
1624
Keysight
KEYS
$58.3B
$32K ﹤0.01%
314
-7,585
-96% -$776K
LRFC
1625
DELISTED
Logan Ridge Finance Corp
LRFC
$32K ﹤0.01%
+603
New +$30.8K

Similar funds

Tower Research Capital (TRC)'s Q4 2019 Portfolio in Review

As of Q4 2019, Tower Research Capital (TRC) held 4,943 positions worth $1.2B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Tower Research Capital (TRC) withdrew a net $342M in Q4 2019, closing 1,310 positions and reducing 1,646 holdings. Its most notable exit was Wells Fargo, an estimated $7.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 9.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2019 buy was iShares Core S&P 500 ETF: 75,634 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $168M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2019 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $52.3M.
  • Tower Research Capital (TRC) fully exited Wells Fargo in Q4 2019, selling an estimated $7.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 51% of its $1.2B portfolio in Q4 2019.
  • Tower Research Capital (TRC) opened 709 new positions and closed 1,310 in Q4 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 17% quarter-over-quarter to $1.2B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2019, filed 7 Feb 2020.